WO2001041819A1 - Preparation absorbante - Google Patents
Preparation absorbante Download PDFInfo
- Publication number
- WO2001041819A1 WO2001041819A1 PCT/EP2000/011578 EP0011578W WO0141819A1 WO 2001041819 A1 WO2001041819 A1 WO 2001041819A1 EP 0011578 W EP0011578 W EP 0011578W WO 0141819 A1 WO0141819 A1 WO 0141819A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogel
- silver
- acid
- insoluble
- forming polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Definitions
- the present invention relates to an absorbent preparation containing
- the proportion of silver being 0.1 to 1000 ppm of the hydrogel-forming polymer and the use of this mixture in hygiene articles for adults and babies and hygiene articles containing them. It also relates to the use of sparingly or insoluble silver salts or colloidal silver in hygiene articles.
- Diaper rash is a common manifestation of skin irritation or inflammation in areas of the body that are usually covered by wearing a diaper.
- diaper dermatitis is a serious problem in adult incontinence.
- diaper dermatitis is a contact dermatitis that arises from long-term contact of the skin with urine and / or faeces.
- the exact components in urine and faeces that are responsible for the occurrence of diaper rash are not yet fully known.
- ammonia, bacteria, fungi, moisture and the skin pH play a decisive role in the development of diaper dermatitis.
- the long-term contact of the skin with urine and feces also leads to the formation of nasty ones
- Skin irritation occurs frequently when the skin's natural protective acid layer is destroyed. This is done by increasing the pH, for example, by decomposing the urea to ammonia by urease.
- EP-A 0 739 635 therefore teaches hydrogels containing sodium tetraborate which act as urease inhibitors.
- EP-A-0 316 518 teaches hydrogels which have a pH of 5.2 to 5.5 when wetted with water. Furthermore, ion-exchanging modified cellulose is described in EP-A-0 202 126 as a covering layer and in EP A-0 202 127 as a core material. All these approaches have in common that the formation of the skin-irritating components is not prevented and the effect wears off with longer contact times.
- EP-A-0 837 077, EP-A-0 839 841 and WO 92/06694 describe the use of quaternary ammonium salts such as cetylpyridinium chloride or didecyldimethylamonium carbonate as microbicidal additives for the hydrogel.
- quaternary ammonium salts such as cetylpyridinium chloride or didecyldimethylamonium carbonate
- US-A-4 556 560 describes the use of water-soluble metal salts, in particular zinc dichloride, for the treatment of the upper cover layer of a diaper to avoid diaper rash.
- WO 95/24173 teaches hygiene articles with a liquid-permeable cover which contains zeolites impregnated with heavy metal ions.
- WO 98/20915 teaches a superabsorbent composition consisting of a superabsorbent polymer and a zeolite, in which the cations have been replaced by metal cations with microbiocidal properties, in particular with silver ions.
- the heavy metal ions can be extracted very easily by exposure to body fluid, so that direct skin contact cannot be excluded. This can lead to undesirable side effects when wearing such incontinence items daily for long periods, for example in the case of silver to skin discoloration and argyria.
- the object was therefore to provide an absorbent preparation which, when used in articles for the absorption of body fluids, enables effective odor control and leaves the skin of the wearer of the article in a healthy state without having the disadvantages mentioned above.
- Absorbent preparation is to be understood as a preparation that contains a hydrogel-forming polymer as the main component.
- the preparation according to the invention preferably consists of a silver salt or colloidal silver which is sparingly or insoluble in water, the hydrogel-forming polymer and, if appropriate, additives customary for hydrogel.
- Insoluble or sparingly soluble silver salts are understood to mean silver salts which have a solubility product in water at 25 ° C. of less than 1 ⁇ 10 ⁇ 8 (mol / L) m + n (for compounds of the Ag ra X n type ).
- Examples of such silver salts are silver bromide, silver chloride, silver iodide, silver molybdate, silver phosphate and silver sulfide. The use of silver chloride is particularly preferred.
- the proportion of colloidal silver or the insoluble or sparingly soluble silver salt in the hydrogel-forming polymer is 0.1 to 1000 ppm, preferably 1 to 1000 ppm and particularly preferably 1 to 500 ppm.
- Suitable polymers (b) are graft (co) polymers of one or more hydrophilic monomers on a suitable graft base, crosslinked cellulose or starch ethers and starch esters bearing acid groups, crosslinked carboxymethyl cellulose, or natural products with acid groups which are swellable in aqueous liquids, such as for example alginates and carrageenans.
- Suitable graft bases can be of natural or synthetic origin. Examples are starch, cellulose or cellulose derivatives and other polysaccharides and oligosaccharides, polyvinyl alcohol, polyalkylene oxides, in particular polyethylene oxides and polypropylene oxides, polyamines, polyamides and hydrophilic polyesters.
- Suitable polyalkylene oxides have, for example, the formula
- R 1 and R 2 independently of one another are hydrogen, alkyl, alkenyl or aryl,
- X is hydrogen or methyl
- n is an integer from 1 to 10,000.
- R 1 and R 2 are preferably hydrogen, (C 1 -C 4 ) alkyl, (C 2 -C 6 ) alkenyl or phenyl.
- Hydrogel-forming polymers (b) are crosslinked polymers with acid groups which are predominantly in the form of their salts, generally alkali metal or ammonium salts. Such polymers swell to form gels on contact with aqueous liquids.
- Polymers (b) which are obtained by crosslinking polymerization or copolymerization of monoethylenically unsaturated monomers bearing acid groups or their salts are preferred. It is also possible to (co) polymerize these monomers without crosslinking agents and to crosslink them subsequently.
- Such monomers bearing acid groups are, for example, monoethylenically unsaturated C 3 -C 5 -carboxylic acids or anhydrides such as acrylic acid, methacrylic acid, ethacrylic acid, ⁇ -chloroacrylic acid, crotonic acid, maleic acid, maleic anhydride, itaconic acid, citraconic acid, mesaconic acid, glutaconic acid, and aconitic acid
- Fumaric acid Also suitable are monoethylenically unsaturated sulfonic or phosphonic acids, for example vinylsulfonic acid, allylsulfonic acid, sulfoethyl acrylate, sulfoethyl methacrylate, sulfopropyl acrylate, sulfopropyl methacrylate, 2-hydroxy-3-acryloxypropanesulfonic acid, 2-hydroxy-3-methacryloxypropanesulfonic acid, vinylphosphonic acid, styllphosphonic acid, allyl sulfonyl acid 2-acrylamido-2-methyl propane sulfonic acid.
- the monomers can be used alone or as a mixture with one another.
- Preferred monomers are acrylic acid, methacrylic acid, vinylsulfonic acid, acrylamidopropanesulfonic acid or mixtures of these acids, e.g. Mixtures of acrylic acid and methacrylic acid, mixtures of acrylic acid and acrylamidopropanesulfonic acid or mixtures of acrylic acid and vinylsulfonic acid.
- monoethylenically unsaturated compounds which do not have an acid group but can be copolymerized with the monomers bearing acid groups.
- monomers bearing acid groups include, for example, the amides and nitriles of monoethylenically unsaturated carboxylic acids, such as acrylamide, methacrylamide and N-vinylformamide,
- N-vinyl acetamide, N-methyl-N-vinyl acetamide, acrylonitrile and methacrylonitrile are, for example, vinyl esters of saturated C ⁇ ⁇ to C 4 carboxylic acids such as vinyl formate, vinyl acetate or vinyl propionate, alkyl vinyl ether with at least 2 C atoms in the alkyl group, such as ethyl vinyl ether or butyl vinyl ether, esters of monoethylenically unsaturated C 3 - to C ⁇ Carboxylic acids, for example esters from monovalent C 1 ⁇ to Cig alcohols and acrylic acid, methacrylic acid or maleic acid, half esters of maleic acid, for example monomethyl maleate, N-vinyl lactams such as N-vinyl pyrrolidone or N-vinyl caprolactam, acrylic acid and methacrylic acid esters of alkoxylated monohydric, saturated Alcohols, for example alcohols with 10 to 25 carbon
- These monomers not bearing acid groups can also be used in a mixture with other monomers, e.g. Mixtures of vinyl acetate and 2-hydroxyethyl acrylate in any ratio. These monomers not carrying acid groups are added to the reaction mixture in amounts between 0 and 50% by weight, preferably less than 20% by weight.
- Crosslinked polymers from monoethylenically unsaturated monomers bearing acid groups are preferred, which are optionally converted into their alkali metal or ammonium salts before or after the polymerization, and from 0 to 40% by weight, based on their total important monoethylenically unsaturated monomers bearing no acid groups.
- Crosslinked polymers (b) of monoethylenically unsaturated C 3 -C 2 -carboxylic acids and / or their alkali metal or ammonium salts are preferred.
- crosslinked polyacrylic acids are preferred, the acid groups of which are 25-100% in the form of alkali or ammonium salts.
- Compounds which have at least 2 ethylenically unsaturated double bonds can function as crosslinkers.
- Examples of compounds of this type are N, N '-methylene bisacrylamide, polyethylene glycol diacrylates and polyethylene glycol dimethacrylates, which are each derived from polyethylene glycols with a molecular weight of 106 to 8500, preferably 400 to 2000, trimethylol propane triacrylate, trimethylol propane trimethacrylate, ethylene glycol propylene diacrylate, Butanediol diacrylate, butanediol dimethacrylate, hexanediol diacrylate, hexanediol dimethacrylate, allyl methacrylate, diacrylates and dimethacrylates of block copolymers of ethylene oxide and propylene oxide, double or triple esterified with acrylic acid or methacrylic acid, and polyhydric alcohols such as glycerol, triethylammonyldih
- water-soluble crosslinking agents are used, e.g. N, N '-methylene bisacrylamide, polyethylene glycol diacrylates and polyethylene glycol dimethacrylates derived from addition products of 2 to 400 moles of ethylene oxide with 1 mole of a diol or polyol, vinyl ethers of addition products with 2 to 400 moles of ethylene oxide with 1 mole of a diol or polyol, ethylene glycol diacrylate , Ethylene glycol dimethacrylate or triacrylate and trimethacrylates of addition products of 6 to 20 moles of ethylene oxide with 1 mole of glycerol, pentaerythritol triallyl ether and / or divinyl urea.
- N, N '-methylene bisacrylamide polyethylene glycol diacrylates and polyethylene glycol dimethacrylates derived from addition products of 2 to 400 moles of ethylene oxide with 1 mole of a diol or polyol
- crosslinkers are compounds which contain at least one polymerizable ethylenically unsaturated group and at least one further functional group.
- the functional group of these crosslinkers must be able to react with the functional groups, essentially the acid groups of the monomers. Suitable functional groups are for example hydroxyl, amino, epoxy and aziridino groups.
- hydroxyalkyl esters of the above-mentioned monoethylenically unsaturated carboxylic acids such as 2-hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl acrylate, hydroxyethyl methacrylate, hydroxypropyl methacrylate and hydroxybutyl methacrylate, allyl piperidinium bromide, N-vinyl imidazole such as N-vinyl imidazole such as N-vinyl imidazole -methylimidazole and N-vinylimidazolines such as N-vinylimidazoline, l-vinyl-2-methylimidazoline, l-vinyl-2-ethyl-imidazoline or l-vinyl-2-propylimidazoline, which are in the form of the free bases, in quaternized form or as a salt can be used in the polymerization.
- N-vinyl imidazole such as N-
- dialkylaminoethyl acrylates and dialkylaminoethyl methacrylates such as dirnethylaminoethyl acrylate, dirnethylaminoethyl methacrylate, diethylaminoethyl acrylate and diethylaminoethyl methacrylate.
- the basic esters are preferably used in quaternized form or as a salt.
- Glycidyl (meth) acrylate can also be used, for example.
- crosslinkers are compounds which contain at least two functional groups which are capable of reacting with the functional groups of the polymers, essentially the acid groups.
- the suitable functional groups are hydroxyl, amino, epoxy, isocyanate, ester, amido and aziridino groups.
- crosslinking agents are ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol, glycerin, polyglycerol, triethanolamine, propylene glycol, polypropylene glycol, block copolymers of ethylene oxide and propylene oxide, ethanolamine, sorbitan fatty acid esters, ethoxylated sorbitan fatty acid, 3-sorbitan fatty acid, 3-sorbitan fatty acid, 3-sorbitan fatty acid, 3-sorbitan fatty acid, 3-sorbitan fatty acid, butanediol, 1, 4-butanediol, polyvinyl alcohol, sorbitol, starch, polyglycidyl ethers such as ethylene glycol, Polyethylenglykoldiglyci - dylether, glycerol diglycid
- Dirnethylaminoethyl (meth) acrylate which are optionally quaternized with, for example, methyl chloride.
- crosslinkers are polyvalent metal ions, which are able to form ionic crosslinks. Examples of such crosslinkers are magnesium, calcium, barium and aluminum ions. These crosslinkers are used, for example, as hydroxides, carbonates or hydrogen carbonates.
- Other suitable crosslinkers are multifunctional bases which are also able to form ionic crosslinks, for example polyamines or their quaternized salts. Examples of polyamines are ethylene diamine, diethylene triamine, triethylene tetramine, tetraethylene pentamine, pentaethylene hexamine and polyethyleneimines and polyamines with molecular weights of up to 4,000,000 each.
- the crosslinkers are present in the reaction mixture, for example from 0.001 to 20% by weight and preferably from 0.01 to 14% by weight.
- the polymerization is initiated as usual by an initiator. It is also possible to initiate the polymerization by the action of electron beams on the polymerizable, aqueous mixture. However, the polymerization can also be initiated in the absence of initiators of the type mentioned above by the action of high-energy radiation in the presence of photoinitiators. All compounds which decompose into free radicals under the polymerization conditions can be used as polymerization initiators, for example peroxides, hydroperoxides, hydrogen peroxide, persulfates, azo compounds and the so-called redox catalysts. The use of water-soluble initiators is preferred.
- mixtures of different polymerization initiators for example mixtures of hydrogen peroxide and sodium or potassium peroxodisulfate.
- Mixtures of hydrogen peroxide and sodium peroxodisulfate can be used in any ratio.
- Suitable organic peroxides are, for example, acetylacetone peroxide, methyl ethyl ketone peroxide, tert-butyl hydroperoxide, cumene hydroperoxide, tert. -Amyl perpivalate, tert-butyl perpivalate, tert. Butyl perneohexanoate, tert. -Butylperisobuty- rat, tert.
- the above-mentioned polyvalent metal ions which can form ionic bonds
- the above-mentioned multifunctional bases which likewise bring about crosslinking via ionic bonds, are suitable for the subsequent crosslinking.
- crosslinkers are added to the acid-bearing polymers or their salts in amounts of 0.5 to 25% by weight, preferably 1 to 15 15% by weight, based on the amount of the polymer used.
- the crosslinked polymers (b) are preferably used in neutralized form in the mixture according to the invention. However, the neutralization can also have been carried out only partially.
- the degree of neutralization is preferably 25 to 100%, in particular 50 to 100%.
- Possible neutralizing agents are:
- Alkali metal bases or ammonia or amines 25 sodium hydroxide solution or potassium hydroxide solution is preferably used.
- the neutralization can also be carried out with the aid of sodium carbonate, sodium hydrogen carbonate, potassium carbonate or potassium hydrogen carbonate or other carbonates or hydrogen carbonates or ammonia.
- prim. , sec. and tert. Amines can be used.
- aqueous solution Polymerization in aqueous solution is preferred as so-called gel polymerization. 10 to 70% by weight aqueous solutions of the monomers and optionally a suitable graft base are polymerized in the presence of a radical initiator using the Trommsdorff-Norrish effect.
- the polymerization reaction can be carried out in the temperature range from 0 to 150.degree. C., preferably from 10 to 100.degree. C., both under normal pressure and under 5 and under elevated or reduced pressure.
- the polymerization can also be carried out in a protective gas atmosphere, preferably under nitrogen.
- the quality properties of the polymers can be improved further by reheating the polymer gels for several hours in the temperature range from 50 to 130 ° C., preferably 70 to 100 ° C.
- Hydrogel-forming polymers (b) which are post-crosslinked are preferred.
- the surface postcrosslinking can take place in a manner known per se with dried, ground and sieved polymer particles.
- compounds which can react with the functional groups of the polymers (b) with crosslinking are preferably applied to the surface of the hydrogel particles in the form of a water-containing solution.
- the water-containing solution can contain water-miscible organic solvents. Suitable solvents are alcohols such as methanol, ethanol, i-propanol or acetone.
- Suitable post-crosslinking agents are, for example
- Di- or polyglycidyl compounds such as phosphonic acid diglycidyl ether or ethylene glycol diglycidyl ether, bischlorohydrin ether of polyalkylene glycols,
- Polyaziridines compounds containing aziridine units based on polyethers or substituted hydrocarbons, for example bis-N-aziridinomethane,
- Polyols such as ethylene glycol, 1, 2-propanediol, 1, 4-butanediol, glycerol, methyltriglycol, polyethylene glycols with an average molecular weight M w of 200-10000, di- and polyglycerol, pentaerythritol, sorbitol, the oxyethylates of these polyols and their Esters with carboxylic acids or carbonic acid such as ethylene carbonate or propylene carbonate,
- Carbonic acid derivatives such as urea, thiourea, guanidine, dicyandiamide, 2-oxazolidinone and its derivatives, bisoxazoline, polyoxazolines, di- and polyisocyanates, Di- and poly-N-methylol compounds such as methylenebis (N-methylol-methacrylamide) or melamine-formaldehyde resins,
- acidic catalysts such as p-toluenesulfonic acid, phosphoric acid, boric acid or ammonium dihydrogen phosphate can be added.
- Particularly suitable post-crosslinking agents are di- or polyglycidyl compounds such as ethylene glycol diglycidyl ether, the reaction products of polyamidoamines with epichlorohydrin and 2-oxazolidinone.
- the crosslinker solution is preferably applied by spraying on a solution of the crosslinker in conventional reaction mixers or mixing and drying systems such as Patterson-Kelly mixers, DRAIS turbulence mixers, Lödige mixers, screw mixers, plate mixers, fluidized bed mixers and Schugi mix.
- a temperature treatment step can follow, preferably in a downstream dryer, at a temperature between 80 and 230 ° C, preferably 80-190 ° C, and particularly preferably between 100 and 160 ° C, over a period of 5 minutes up to 6 hours, preferably 10 minutes to 2 hours and particularly preferably 10 minutes to 1 hour, it being possible for both cleavage products and solvent fractions to be removed.
- drying can also take place in the mixer itself, by heating the jacket or by blowing in a preheated carrier gas.
- the hydrophilicity of the particle surface polymer (b) is additionally modified by the formation of complexes.
- the complexes are formed on the outer shell of the hydrogel particles by spraying on solutions of divalent or polyvalent metal salt solutions, the metal cations being able to react with the acid groups of the polymer to form complexes.
- divalent or polyvalent metal cations are Mg 2+ , Ca 2+ , Al 3+ , Sc 3+ , Ti + , Mn + , Fe 2+ / 3+ , Co 2+ , Ni 2+ , Cu + / + , Zn 2+ , Y 3+ , Zr + , Ag + , La 3+ , Ce 4+ , Hf + , and Au + / 3+
- preferred metal cations are Mg 2+ , Ca 2+ , Al 3+ , Ti 4+ , Zr 4+ and La 3+
- particularly preferred metal cations are Al 3+ , Ti 4+ and Zr 4+ .
- salts are suitable which have sufficient solubility in the solvent to be used.
- a solvent for the Salts can be water, alcohols, DMF, DMSO and mixtures of these components. Water and water / alcohol mixtures such as water / methanol or water / 1, 2-propanediol are particularly preferred.
- the salt solution can be sprayed onto the particles of the hydrogel-forming polymer both before and after the surface post-crosslinking of the particles.
- the salt solution is sprayed on in the same step as the spraying of the crosslinking agent solution, with both solutions being sprayed on separately in succession or simultaneously via two nozzles, or the crosslinking agent and salt solution being sprayed together via a nozzle.
- a further modification of the particles of polymer (b) can be carried out by admixing finely divided inorganic solids, such as, for example, silica, bentonite, aluminum oxide, titanium dioxide and iron (II) oxide, which further enhances the effects of surface treatment.
- finely divided inorganic solids such as, for example, silica, bentonite, aluminum oxide, titanium dioxide and iron (II) oxide.
- hydrophilic silica or of is particularly preferred
- Aluminum oxide with an average primary particle size of 4 to 50 nm and a specific surface area of 50-450 m 2 / g. Fine inorganic solids are preferably added after the surface modification by crosslinking / complex formation, but can also be carried out before or during these surface modifications.
- colloidal silver or the insoluble or sparingly soluble silver salt can be introduced into the hydrogel-forming polymer in various ways.
- colloidal silver or the insoluble or sparingly soluble silver salts can be added to the monomer solution before the polymerization, or the addition takes place at any time during the preparation of the hydrogel-forming polymer, for example during or after the polymerization.
- colloidal silver or insoluble or sparingly soluble silver salts can be applied to the already dried hydrogel-forming polymer particles, for example by spraying on an emulsion or dispersion which contains colloidal silver or insoluble or sparingly soluble silver salts, or by addition Corresponding emulsions or dispersions to the surface postcrosslinker solution to be applied to the hydrogel particles.
- colloidal silver or insoluble or sparingly soluble silver salts to the hydrogel by means of a powder mixture.
- the resulting hydrogel-forming polymer contains the colloidal silver or the insoluble or sparingly soluble silver salts, depending on the time of addition, evenly distributed or reinforced on its surface. Hydrogel whose surface has been treated with colloidal silver or insoluble or sparingly soluble silver salts is particularly preferred.
- an insoluble or sparingly soluble silver salt is used, which is located on an inert carrier material.
- Inert here is understood to mean that the carrier material does not form, swell or even dissolve in contact with water or aqueous solutions.
- the carrier material is preferably oxidic in nature, ie it is an oxide, a hydroxide or contains oxy anions such as sulfate or phosphate. Examples of such materials are the oxides of titanium, magnesium, aluminum, silicon, cerium, zirconium, hafnium, niobium and tantalum, calcium hydroxyapatite and barium sulfate. Titanium dioxide and silicon dioxide are particularly preferred.
- the particle size of the inert carrier material is less than 500 ⁇ m, preferably less than 100 ⁇ m, and is particularly preferably in the range from 1 to 15 ⁇ m.
- the specific surface area of the inert carrier material is at least 1 g / m 2 , preferably at least 5 g / m 2 and is particularly preferably in the range from 5 to 100 g / m 2 .
- the content of sparingly soluble or insoluble silver salt on the inert carrier material is 0.1-90% by weight, based on the carrier material, and preferably 10-60% by weight.
- Silver chloride is preferably used as the insoluble or poorly soluble silver salt.
- the hydrogel-forming polymer contains, in addition to colloidal silver or an insoluble or sparingly soluble silver salt, a nonionic, anionic, cationic or amphoteric surfactant with an HLB value greater than or equal to 3 (definition of the HLB value: see WC Griffin, J. Soc. Cosmetic Chem. 5 (1954) 249).
- Preferred surfactants are those which are soluble or at least dispersible in water.
- Suitable nonionic surfactants are, for example, the addition products of ethylene oxide, propylene oxide or mixtures of ethylene oxide and propylene oxide with alkylphenols, aliphatic alcohols, carboxylic acids and amines.
- alkylphenols aliphatic alcohols
- carboxylic acids and amines for example, Cs-C ⁇ -alkylphenols alkoxylated with ethylene oxide and / or propylene oxide are suitable.
- Commercial products of this type are, for example, octylphenols or nonylphenols, which are each reacted with 4 to 20 moles of ethylene oxide per mole of phenol.
- nonionic surfactants are ethoxylated C 10 -C 24 fatty alcohols or ethoxylated Cio to C 2 fatty acids as well as ethoxylated C ⁇ o C 24 fatty amines or ethoxylated C 1 -C 2 fatty acid amides.
- partially esterified with C 1 -C 24 -fatty acids are polyhydric C 3 - to C 6 -alcohols. These esters can additionally be reacted with 2 to 20 moles of ethylene oxide.
- Suitable fatty alcohols which are alkoxylated to produce the surfactants are, for example
- the fatty alcohols are ethoxylated or propoxylated to such a degree or reacted with ethylene oxide and propylene oxide that the reaction products are soluble in water.
- 1 mol of the above-mentioned fatty alcohols is reacted with 2 to 20 mol of ethylene oxide and optionally up to 5 mol of propylene oxide in such a way that surfactants are obtained which have an HLB value of more than 8.
- C - to C ⁇ -alcohols which are partially esterified and optionally ethoxylated are, for example, glycerol, sorbitol, mannitol and pentaerythritol.
- These polyhydric alcohols are partially esterified with C ⁇ o to C 24 fatty acids, such as oleic acid, stearic acid or palmitic acid. The esterification with the fatty acids takes place at most to such a degree that at least one OH group of the polyhydric alcohol remains unesterified.
- Suitable esterification products are, for example, sorbitan mono-oleate, sorbitan tristearate, manit monooleate, glycerol onooleate and glycerol dioleate.
- the fatty acid esters of polyhydric alcohols mentioned which still contain at least one free OH group, can also be reacted with ethylene oxide, propylene oxide or mixtures of ethylene oxide and propylene oxide for modification. 2 to 20 moles of the alkylene oxides mentioned are preferably used per mole of fatty acid ester.
- the degree of ethoxylation has an influence on the HLB value of the nonionic surfactants.
- surfactants with HLB values in a range from 3 to 20 can be produced in a technically simple manner.
- Another group of suitable substances are homopolymers of ethylene oxide, block copolymers of ethylene oxide and alkylene oxides, preferably propylene oxide, and polyfunctional block copolymers which are formed, for example, by sequential addition of propylene oxide and ethylene oxide to diamines.
- alkyl polyglycosides such as those marketed by Henkel as APG®, Glucopan® and Plantaren®.
- the nonionic surfactants can be used either alone or in a mixture with one another.
- Suitable anionic surfactants are C 8 to C 24 alkyl sulfonates, which are preferably used in the form of the alkali salts, C B to C 24 alkyl sulfates, which are preferably used in the form of the alkali metal or trialkanol ammonium salts, such as triethanolammonium lauryl sulfate, Sulfosuccinic acid diesters, for example the sodium salt of sulfosuccinic acid di (2-ethylhexyl) ester or sodium dioctyl sulfosuccinate, sulfosuccinic acid semiesters, such as, for example
- Suitable cationic surfactants are the salts of fatty amines, for example coconut fat ammonium acetate, quaternary fatty acid amino esters, for example isopropyl difatty acid dimethylammonium methosulfate, quaternary fatty acid aminoamides, for example N-undecylenic acid propylamino-N-trimethylammonidene anoxides of fatty amines and salamino methylene sulfates, or , such as pentoxethylstearylammonium acetate or ethoxylated methyloleinamine methosulfate and long-chain alkylbenzyldimethylammonium compounds, such as C 0 - to C 22 alkylbenzyldimethylammonium chloride.
- fatty amines for example coconut fat ammonium acetate
- quaternary fatty acid amino esters for example isopropyl difatty acid dimethylammonium methosul
- amphoteric surfactants are compounds which carry at least one quaternary ammonium cation and at least one carboxylate or sulfate anion in the same molecule, such as dimethylcarboxymethyl fatty acid alkylamidoammonium betaines or 3- (3-fatty acid amidopropyl) dimethylammonium 2-hydroxypropane sulfonates.
- the ionic surfactants can be used alone or as a mixture with one another.
- the surfactants are used in amounts of 0.0001 to 5% by weight, preferably 0.01 to 2.5% by weight, based on the hydrogel-forming polymer.
- the use of sulfosuccinates such as sodium dioctyl sulfosuccinate or sodium lauryl sulfosuccinate is preferred.
- the surfactant can be incorporated into the hydrogel-forming polymer.
- the hydrogel-forming polymer contains, in addition to colloidal silver or insoluble or sparingly soluble silver salts and optionally surfactants, additives with fungicidal properties.
- Suitable additives are, for example, 3-iodo-2-propynyl butyl carbamate, Diidomethyl-p-tolyl sulfone, 2,4,4 'trichloro-2' hydroxydiphenyl ether and 2-bromo-2-nitro-1,3-propanediol.
- 3-iodo-2-propynyl butyl carbamate is particularly preferred.
- the additives are used in amounts of 1 to 10,000 ppm, preferably 10 to 1000 ppm, based on the hydrogel-forming polymer.
- the additives can be introduced into the hydrogel-forming polymer in a manner similar to colloidal silver or the insoluble or poorly soluble silver salt.
- the pH of the absorbent preparation according to the invention is in the range from 3 to 7, preferably from 4 to 6 and particularly preferably from 4.5 to 6.
- the absorbent preparations according to the invention have good fungicidal and bactericidal properties.
- the hygiene articles containing them show good skin tolerance.
- the present invention relates to comprehensive hygiene articles
- (E) optionally a receiving layer located between (A) and (C).
- Hygiene articles mean both incontinence pads and incontinence pants for adults and diapers for babies.
- the liquid-permeable cover (A) is the layer that has direct skin contact.
- the material is conventional synthetic and semi-synthetic fibers or films such as polyester, polyolefins, rayon or natural fibers such as cotton. With non-woven materials, the fibers are in the Usually linked by binders such as polyacrylates. Preferred materials are polyester, rayon and their blends, polyethylene and polypropylene.
- the liquid-impermeable layer (B) generally consists of a film made of polyethylene or polypropylene.
- the core (C) contains hydrophilic fiber material (C2).
- Hydrophilic is understood to mean that aqueous liquids are quickly distributed over the fiber.
- the fiber material is cellulose, modified cellulose, rayon, polyester such as polyethylene terephthalate. Cellulose fibers such as cellulose are particularly preferred.
- the fibers usually have a diameter of 1 - 200 ⁇ m, preferably 10 - 100 ⁇ m. In addition, the fibers have a minimum length of 1 mm.
- the proportion of the hydrophilic fiber material based on the total amount of the core is preferably 20-80% by weight, particularly preferably 40-70% by weight.
- the structure and shape of diapers is generally known and is described, for example, in EP-A-0 316 518 and EP-A-0 202 127.
- 1 g absorbing mixture was mixed with 100 ml synthetic urine replacement solution and 0.1 ml germ solution (approx. 1 - 5 x 10 8 CFU per ml germ suspension) was added.
- the synthetic urine replacement solution contained 0.64 g CaCl 2 , 1.14 g MgSO 4 ⁇ 7 H 2 O, 8.20 g NaCl and 20.0 g urea per 1000 ml demineralized water.
- the contaminated Test solution was incubated at 37 ° C. with shaking at 100 rpm in a water bath. At 0 minutes, after 6 and 23 hours, 10 ml of contaminated test solution were mixed with 90 ml of caso broth and inactivating substances. 1 ml of the inactivation broth 5 is mixed with Caso agar and 0.1 ml of the inactivation broth is spatulated out on Caso agar + HLT.
- 25 hydrogel was sprayed in a plowshare mixer with a solution consisting of 25 g deionized water, 40 g of methanol and 20 of a 15 wt .-% w aqueous solution of a polyamidoamine-epichlorohydrin adduct (RETEN ® 204 LS of Messrs. Hercules) and then annealed at 140 ° C for 60 minutes. After cooling
- the product in the ploughshare mixer was sprayed with a mixture of 50 ppm silver protein (Aldrich, mild silver protein, colloidal silver, approx. 20% Ag) and 2.5% by weight of deionized water, based in each case on the polymer.
- the microbicidal effectiveness of the product described here was
- JM ActiCare TM from Johnson Matthey PLC, contains 2% silver chloride, 8% titanium dioxide and 5-25% sodium dioctyl sulfosuccinate) and 500 g of deionized water, homogeneously kneaded, crushed, dried, ground and sieved.
- Example 3 The procedure was as in Example 2, but an additional 0.02% by weight of the additives listed in Table 3 was added to the postcrosslinker solution. The microbicidal activity of the products is shown in Table 3.
- Example 4 The procedure was as in Example 1, but the product was not sprayed with a silver protein emulsion.
- the microbicidal activity of the product is shown in Table 4.
- Example 5 The procedure was as in Example 2, but the suspension was not mixed with the silver chloride.
- the microbicidal activity of the product is shown in Table 5.
- the hydrogel-forming polymers obtained according to Examples 1 to 3 are distinguished by excellent microbicidal activity and are therefore excellent as absorbents for water and aqueous liquids, in particular body fluids, such as e.g. Urine or blood, suitable for example in hygiene articles such as Baby and adult diapers, sanitary napkins, tampons and the like.
- body fluids such as e.g. Urine or blood
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
L'invention concerne une préparation absorbante contenant (a) un sel d'argent ou un argent colloïdal peu soluble ou insoluble dans l'eau et (b) un polymère formant un hydrogel. La préparation selon l'invention est caractérisée en ce que la proportion d'argent est de 0,1 à 1000 ppm du polymère formant un hydrogel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999158697 DE19958697A1 (de) | 1999-12-06 | 1999-12-06 | Absorbierende Zubereitung |
| DE19958697.7 | 1999-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2001041819A1 true WO2001041819A1 (fr) | 2001-06-14 |
Family
ID=7931561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2000/011578 Ceased WO2001041819A1 (fr) | 1999-12-06 | 2000-11-21 | Preparation absorbante |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE19958697A1 (fr) |
| WO (1) | WO2001041819A1 (fr) |
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003090799A1 (fr) * | 2002-04-23 | 2003-11-06 | Stockhausen Gmbh | Particules polymeres hydroabsorbantes retardant la decomposition de fluides corporels, composites contenant ces particules et utilisation de ces particules et composites |
| US6939568B2 (en) | 2001-04-23 | 2005-09-06 | Nucryst Pharmaceuticals Corp. | Treatment of inflammatory skin conditions |
| US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
| US7078060B2 (en) | 2000-07-27 | 2006-07-18 | Nucryst Pharmaceuticals Corp. | Solutions and aerosols of metal-containing compounds |
| US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
| CN1300241C (zh) * | 2004-10-15 | 2007-02-14 | 中国科学院理化技术研究所 | 抗菌高吸水性聚合物复合材料及其制备方法 |
| US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
| US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
| WO2007002705A3 (fr) * | 2005-06-24 | 2007-11-15 | Inframat Corp | Composite antimicrobien, procede de fabrication et utilisation |
| US7312268B2 (en) * | 2001-06-29 | 2007-12-25 | Stockhausen Gmbh | Water-absorbent carboxyl-containing polymers with low monomer content |
| US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
| US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
| WO2009061270A1 (fr) * | 2007-11-05 | 2009-05-14 | Abigo Medical Ab | Dispositif pour le traitement d'une mycose vaginale |
| WO2009040358A3 (fr) * | 2007-09-25 | 2010-04-01 | Basf Se | Superabsorbant à additif inhibiteur de virus |
| US7825169B2 (en) | 2002-06-06 | 2010-11-02 | Nippon Shokubai Co. Ltd. | Water-absorbent composition, process for production thereof, absorbent and absorbing product |
| EP1404283B2 (fr) † | 2001-06-29 | 2011-02-23 | Evonik Stockhausen GmbH | Polymeres superabsorbants a base de carboxyle presentant des proprietes desodorisantes et procede de fabrication associe |
| EP1404385B2 (fr) † | 2001-06-29 | 2011-07-06 | Evonik Stockhausen GmbH | Polymeres superabsorbants contenant un carboxyle et presentant des proprietes d'elimination des odeurs, et procede de preparation associe |
| US8067663B2 (en) | 2002-02-11 | 2011-11-29 | Bio-Gate Ag | Absorbent sanitary article for absorbing body fluid |
| CN103013037A (zh) * | 2012-12-14 | 2013-04-03 | 山东圣泉化工股份有限公司 | 一种湿帘纸用酚醛树脂改性剂及湿帘用酚醛树脂 |
| US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
| US9440001B2 (en) | 2013-03-06 | 2016-09-13 | Specialty Fibres and Materials Limited | Absorbent materials |
| EP3558401B1 (fr) * | 2016-12-23 | 2022-12-07 | Paul Hartmann AG | Composition aqueuse d'hydrogel contenant des particules élémentaires d'argent |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10309558A1 (de) * | 2003-03-04 | 2004-09-23 | Nanoparc Gmbh | Verbandmaterialien mit modifizierter Oberfläche und Verfahren zu deren Herstellung |
| US7285576B2 (en) | 2003-03-12 | 2007-10-23 | 3M Innovative Properties Co. | Absorbent polymer compositions, medical articles, and methods |
| WO2004080499A1 (fr) * | 2003-03-12 | 2004-09-23 | 3M Innovative Properties Company | Compositions polymeres contenant des composes bioactifs d'argent, de cuivre ou de zinc, articles medicaux et procedes associes |
| US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
| US8399027B2 (en) | 2005-04-14 | 2013-03-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
| DE102005036992A1 (de) * | 2005-08-05 | 2007-02-08 | Schill + Seilacher Aktiengesellschaft | Superabsorberpulver und dessen Verwendung |
| WO2007016970A1 (fr) | 2005-08-05 | 2007-02-15 | Schill+Seilacher Aktiengesellschaft | Superabsorbant, non tisses a base de nanofibres ayant subi un finissage au moyen de ce dernier et leur utilisation |
| US20070166399A1 (en) | 2006-01-13 | 2007-07-19 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
| WO2008024426A2 (fr) * | 2006-08-24 | 2008-02-28 | Neuwirth Robert S | Articles absorbants contenant des nanoparticules d'argent |
| CA2767884A1 (fr) | 2009-07-20 | 2011-01-27 | Awds Technologies Srl | Gaine de guidage de fil, en particulier une gaine de fil de soudure, comprenant un moyen de sollicitation entre des corps de guidage articules |
| US8389901B1 (en) | 2010-05-27 | 2013-03-05 | Awds Technologies Srl | Welding wire guiding liner |
| US8882018B2 (en) | 2011-12-19 | 2014-11-11 | Sidergas Spa | Retainer for welding wire container and welding wire container with retainer |
| US10343231B2 (en) | 2014-05-28 | 2019-07-09 | Awds Technologies Srl | Wire feeding system |
| US10010962B1 (en) | 2014-09-09 | 2018-07-03 | Awds Technologies Srl | Module and system for controlling and recording welding data, and welding wire feeder |
| US10350696B2 (en) | 2015-04-06 | 2019-07-16 | Awds Technologies Srl | Wire feed system and method of controlling feed of welding wire |
| US9950857B1 (en) | 2016-10-17 | 2018-04-24 | Sidergas Spa | Welding wire container |
| US11174121B2 (en) | 2020-01-20 | 2021-11-16 | Awds Technologies Srl | Device for imparting a torsional force onto a wire |
| US11278981B2 (en) | 2020-01-20 | 2022-03-22 | Awds Technologies Srl | Device for imparting a torsional force onto a wire |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1018454A (en) * | 1962-10-18 | 1966-01-26 | Smith Kline French Lab | Improvements in or relating to antibacterial and antifungal compositions |
| US4376764A (en) * | 1981-08-10 | 1983-03-15 | Basf Wyandotte Corporation | Silver ion gel compositions |
| EP0202127A2 (fr) * | 1985-05-15 | 1986-11-20 | The Procter & Gamble Company | Articles absorbants jetables |
| US4728323A (en) * | 1986-07-24 | 1988-03-01 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressings |
| EP0311344A2 (fr) * | 1987-10-09 | 1989-04-12 | The Procter & Gamble Company | Article absorbant jetable pour incontinent |
| EP0316518A2 (fr) * | 1987-11-13 | 1989-05-24 | Vp - Schickedanz Ag | Article hygiénique en cellulose |
| EP0389015A2 (fr) * | 1989-03-20 | 1990-09-26 | The Procter & Gamble Company | Structures absorbantes avec moyens de contrôle de l'odeur |
| EP0509708A1 (fr) * | 1991-04-13 | 1992-10-21 | The Dow Chemical Company | Particules de résine absorbante ayant une surface réticulée et revêtues de tensio-actif et procédé de préparation |
| US5336212A (en) * | 1989-04-27 | 1994-08-09 | Giovanni De Francesco | Antiseptic and antifermentative sanitary towels particularly nappies and pants, for infants, women and incontinent adults |
| US5662913A (en) * | 1991-04-10 | 1997-09-02 | Capelli; Christopher C. | Antimicrobial compositions useful for medical applications |
| WO1998020915A1 (fr) * | 1996-11-13 | 1998-05-22 | Ceca S.A. | Composition superabsorbante pour articles d'hygiene ne developpant pas d'odeurs incommodantes |
-
1999
- 1999-12-06 DE DE1999158697 patent/DE19958697A1/de not_active Withdrawn
-
2000
- 2000-11-21 WO PCT/EP2000/011578 patent/WO2001041819A1/fr not_active Ceased
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1018454A (en) * | 1962-10-18 | 1966-01-26 | Smith Kline French Lab | Improvements in or relating to antibacterial and antifungal compositions |
| US4376764A (en) * | 1981-08-10 | 1983-03-15 | Basf Wyandotte Corporation | Silver ion gel compositions |
| EP0202127A2 (fr) * | 1985-05-15 | 1986-11-20 | The Procter & Gamble Company | Articles absorbants jetables |
| US4728323A (en) * | 1986-07-24 | 1988-03-01 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressings |
| EP0311344A2 (fr) * | 1987-10-09 | 1989-04-12 | The Procter & Gamble Company | Article absorbant jetable pour incontinent |
| EP0316518A2 (fr) * | 1987-11-13 | 1989-05-24 | Vp - Schickedanz Ag | Article hygiénique en cellulose |
| EP0389015A2 (fr) * | 1989-03-20 | 1990-09-26 | The Procter & Gamble Company | Structures absorbantes avec moyens de contrôle de l'odeur |
| US5336212A (en) * | 1989-04-27 | 1994-08-09 | Giovanni De Francesco | Antiseptic and antifermentative sanitary towels particularly nappies and pants, for infants, women and incontinent adults |
| US5662913A (en) * | 1991-04-10 | 1997-09-02 | Capelli; Christopher C. | Antimicrobial compositions useful for medical applications |
| EP0509708A1 (fr) * | 1991-04-13 | 1992-10-21 | The Dow Chemical Company | Particules de résine absorbante ayant une surface réticulée et revêtues de tensio-actif et procédé de préparation |
| WO1998020915A1 (fr) * | 1996-11-13 | 1998-05-22 | Ceca S.A. | Composition superabsorbante pour articles d'hygiene ne developpant pas d'odeurs incommodantes |
Cited By (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
| US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
| US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
| US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
| US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| US7078060B2 (en) | 2000-07-27 | 2006-07-18 | Nucryst Pharmaceuticals Corp. | Solutions and aerosols of metal-containing compounds |
| US6939568B2 (en) | 2001-04-23 | 2005-09-06 | Nucryst Pharmaceuticals Corp. | Treatment of inflammatory skin conditions |
| US6989156B2 (en) | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
| US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
| US7087249B2 (en) | 2001-04-23 | 2006-08-08 | Nucryst Pharmaceuticals Corp. | Treatment of mucosal membranes |
| US7312268B2 (en) * | 2001-06-29 | 2007-12-25 | Stockhausen Gmbh | Water-absorbent carboxyl-containing polymers with low monomer content |
| EP1404385B2 (fr) † | 2001-06-29 | 2011-07-06 | Evonik Stockhausen GmbH | Polymeres superabsorbants contenant un carboxyle et presentant des proprietes d'elimination des odeurs, et procede de preparation associe |
| EP1404283B2 (fr) † | 2001-06-29 | 2011-02-23 | Evonik Stockhausen GmbH | Polymeres superabsorbants a base de carboxyle presentant des proprietes desodorisantes et procede de fabrication associe |
| US8067663B2 (en) | 2002-02-11 | 2011-11-29 | Bio-Gate Ag | Absorbent sanitary article for absorbing body fluid |
| US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
| CN1325122C (zh) * | 2002-04-23 | 2007-07-11 | 施拖克豪森有限公司 | 延缓体液分解的吸水性聚合物颗粒,它们的复合物及其用途 |
| WO2003090799A1 (fr) * | 2002-04-23 | 2003-11-06 | Stockhausen Gmbh | Particules polymeres hydroabsorbantes retardant la decomposition de fluides corporels, composites contenant ces particules et utilisation de ces particules et composites |
| DE10218147B4 (de) * | 2002-04-23 | 2005-12-22 | Stockhausen Gmbh | Wasserabsorbierende, die Zersetzung von Körperflüssigkeiten verzögernde Polymerteilchen, deren Herstellung und Verwendung |
| DE10218147A1 (de) * | 2002-04-23 | 2003-11-20 | Stockhausen Chem Fab Gmbh | Wasserabsorbierende, die Zersetzung von Körperflüssigkeiten verzögerndes Polymerteilchen, diese beinhaltende Verbunde sowie deren Verwendung |
| US7625957B2 (en) | 2002-04-23 | 2009-12-01 | Stockhausen Gmbh | Water-absorbing polymer particles delaying the decomposition of body fluids, composites comprising these and use thereof |
| US7825169B2 (en) | 2002-06-06 | 2010-11-02 | Nippon Shokubai Co. Ltd. | Water-absorbent composition, process for production thereof, absorbent and absorbing product |
| CN1300241C (zh) * | 2004-10-15 | 2007-02-14 | 中国科学院理化技术研究所 | 抗菌高吸水性聚合物复合材料及其制备方法 |
| WO2007002705A3 (fr) * | 2005-06-24 | 2007-11-15 | Inframat Corp | Composite antimicrobien, procede de fabrication et utilisation |
| WO2009040358A3 (fr) * | 2007-09-25 | 2010-04-01 | Basf Se | Superabsorbant à additif inhibiteur de virus |
| WO2009061270A1 (fr) * | 2007-11-05 | 2009-05-14 | Abigo Medical Ab | Dispositif pour le traitement d'une mycose vaginale |
| EP3441054A1 (fr) * | 2007-11-05 | 2019-02-13 | Abigo Medical Ab | Dispositif pour le traitement d'une infection fongique vaginale |
| US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
| CN103013037A (zh) * | 2012-12-14 | 2013-04-03 | 山东圣泉化工股份有限公司 | 一种湿帘纸用酚醛树脂改性剂及湿帘用酚醛树脂 |
| CN103013037B (zh) * | 2012-12-14 | 2015-02-18 | 山东圣泉新材料股份有限公司 | 一种湿帘纸用酚醛树脂改性剂及湿帘用酚醛树脂 |
| US9440001B2 (en) | 2013-03-06 | 2016-09-13 | Specialty Fibres and Materials Limited | Absorbent materials |
| EP3558401B1 (fr) * | 2016-12-23 | 2022-12-07 | Paul Hartmann AG | Composition aqueuse d'hydrogel contenant des particules élémentaires d'argent |
Also Published As
| Publication number | Publication date |
|---|---|
| DE19958697A1 (de) | 2001-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001041819A1 (fr) | Preparation absorbante | |
| DE10218147B4 (de) | Wasserabsorbierende, die Zersetzung von Körperflüssigkeiten verzögernde Polymerteilchen, deren Herstellung und Verwendung | |
| EP1232191B1 (fr) | Polymeres stables mecaniquement formant des hydrogels | |
| EP1682192B1 (fr) | Hydrogel absorbant le sang et/ou des liquides organiques | |
| EP1165638B1 (fr) | Hydrogels reticules, hydrophiles, a forte capacite de gonflement, et procede de preparation et d'utilisation desdits hydrogels | |
| EP1375537B1 (fr) | Polymères hydroabsorbants avec des molecules creuses supramoléculaires, leur procédé de préparation et leur utilisation | |
| DE68924249T2 (de) | Verfahren zur Herstellung eines absorbierenden Harzes mit guter Beständigkeit. | |
| DE69428833T2 (de) | Absorbierende Zusammensetzung und Wegwerfwindel mit dieser Zusammensetzung | |
| DE69534257T3 (de) | Wasserabsorptionsmittel, Verfahren zu seiner Herstellung und wasserabsorbierende Zusammensetzung | |
| EP1366111B2 (fr) | Produit hydrophile, son procede de production et son utilisation | |
| EP1335756B1 (fr) | Agent d'absorption hautement gonflable et a faible tendance a s'agglomerer | |
| EP1996242B1 (fr) | Superabsorbant présentant une capacité accrue d'inhibition des odeurs | |
| EP1363682A1 (fr) | Hydrogels revetus de separateurs steriques ou electrostatiques | |
| EP1427452A1 (fr) | Hydrogels superabsorbants presentant une repartition granulometrique determinee | |
| DE19846412A1 (de) | Hydrophile hochquellfähige Hydrogele sowie Verfahren zu ihrer Herstellung und Verwendung | |
| EP1458423B1 (fr) | Superabsorbants contenant du tocopherol | |
| WO2001068156A1 (fr) | Polymeres hydrophiles, gonflants, formant des hydrogels et comprenant du silicate d'aluminium | |
| EP2429597A2 (fr) | Compositions désodorisantes | |
| DE19813443A1 (de) | Wasser- und wäßrige Flüssigkeiten absorbierende Polymerisatteilchen, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| EP1210129A1 (fr) | Polymeres absorbant l'eau dotes de composes a espaces vides | |
| WO2000076559A1 (fr) | Melange absorbant | |
| DE10351267A1 (de) | Blut und/oder Körperflüssigkeiten absorbierendes Hydrogel | |
| EP2209503A2 (fr) | Superabsorbant à additif inhibiteur de virus | |
| DE102005018923A1 (de) | Wasserabsorbierende Polymergebilde mit verbesserten Absorptionseigenschaften | |
| WO2009056436A2 (fr) | Matériau composite comprenant un polymère superabsorbant et un support et procédé de production de ce matériau par polymérisation du support en présence du polymère superabsorbant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP MX US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |